Plain-English translation of NCT06313333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This is a national registry study in Italy that invites adults with moderate to severe atopic dermatitis to share their medical history, clinical information, and how the disease affects their daily life. The researchers are building a comprehensive database to understand atopic dermatitis better in adults, including those who developed it in childhood and those who developed it as adults. By gathering this information from many patients, they hope to identify clearer diagnostic criteria and improve how doctors diagnose and treat this condition.
Currently, there is no simple blood test or lab marker to diagnose atopic dermatitis, and doctors don't have a clear, agreed-upon pathway for evaluating and treating adults with the disease. By collecting detailed information from many adult patients in one national register, researchers can learn how common this condition really is, identify patterns, and eventually develop better diagnostic guidelines to help future patients get faster, more accurate diagnoses.
You likely qualify if…
You likely don't qualify if…
As a participant, you would provide detailed information about your atopic dermatitis—including when it started, your medical history, your current symptoms, and how the condition impacts your quality of life and daily activities. The study involves sharing this information with the national register, likely through interviews or questionnaires with dermatology specialists. There are no medications being tested; this is a data-collection study, so your main responsibility is to provide accurate information about your condition and experiences.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy
Sponsor
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Enrollment target
~1,500 participants
Started
June 2020
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Piergiacomo MD Calzavara Pinton
Asst Degli Spedali Civili Di Brescia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.